| abstract |
The present invention relates to a novel bacteriophage (Bacteriophage), and more particularly, the main causative agents of Staphylococcus aureus of animal diseases, including human (Staphylococcus It relates to a bacteriophage having the ability to specifically kill aureus ), a pharmaceutical composition for treating diseases caused by Staphylococcus aureus comprising the bacteriophage as an active ingredient, antibiotics and disinfectants.n n n n Staphylococcus aureus, antibiotics, bacteriophage |